OTHER RELEVANT INFORMATION
PLÁSTICOS COMPUESTOS, S.A. 14 May 2026Pursuant to the provisions of Article 17 of Regulation (EU) No 596/2014 on Market Abuse and Article 227 of Law 6/2023 of 17 March on Securities Markets and Investment Services, and related provisions, as well as Circular 3/2020 of 30 July 2020 on information to be provided by companies listed on BME Growth, Plásticos Compuestos, S.A. (the "Company") hereby provides the following information:
The Company's Board of Directors has resolved to convene a General Meeting of Shareholders of the Company, to be held at Carrer Basters 15, Palau Solità i Plegamans (Barcelona) on 17 June 2026, at 12:00 noon, on first call or, if the necessary quorum is not reached, on second call, on 18 June 2026 at the same place and time.
Attached as an Annex is the full text of the notice of meeting, which will be published today on the Company's website (https://www.kompuestos.com) together with the information for shareholders prior to the General Meeting.
In compliance with the provisions of Circular 3/2020 of the BME Growth segment of BME MTF Equity, it is hereby expressly stated that the information provided herein has been prepared under the sole responsibility of the Company and its directors.
We remain at your disposal for any clarifications you may require. In Palau-Solità i Plegamans (Barcelona), on 14 May 2026.
Corporation Chimique International S.P.R.L.
P.p. Mr Ignacio Duch Tuesta Chairman of the Board of Directors
PLÁSTICOS COMPUESTOS, S.A.NOTICE OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
The Board of Directors of PLÁSTICOS COMPUESTOS, S.A. (the "Company"), in accordance with the applicable legal and statutory provisions, has resolved to convene an Ordinary General Meeting of Shareholders, to be held at Carrer Basters 15, Palau Solità i Plegamans (Barcelona) on 17 June 2026, at 12:00 noon, on first call; or, should the necessary quorum not be reached, on second call, on 18 June 2026 at the same place and time, so that the shareholders may deliberate and resolve on the items on the following
AGENDA
Confirmation of the valid constitution of the ordinary general meeting of shareholders, the agenda and the appointments of the chairman and secretary.
Examination and approval, where applicable, of the annual accounts and the management report for the financial year ended 31 December 2025.
Approval of the proposed appropriation of profits for the financial year ended 31 December 2025.
Review and approval of the management and conduct of the Board of Directors and its Audit Committee during the 2025 financial year.
Removal of members of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Appointment of a member of the Company's Board of Directors.
Confirmation of the appointment of Mr Josep Maria Torner Ribe as an independent director by co-optation.
Approval of the remuneration of the members of the Board of Directors for the 2027 financial year.
Authorisation for the Board of Directors, in accordance with the provisions of Article
297.1.b) of the Companies Act, to increase the share capital on one or more occasions and at any time, within a period of 5 years, through cash contributions and up to a maximum nominal amount of €4,049,670.30. Delegation of powers to exclude preemptive subscription rights, in accordance with the provisions of Article 506 of the Companies Act. Revocation of the aforementioned authorisations.
Authorisation for the Board of Directors to issue securities convertible into shares of the Company within a period of 5 years. Establishment of criteria for determining the terms and conditions of conversion and conferral of powers to increase capital. Delegation to exclude pre-emptive subscription rights, in accordance with the provisions of Article 506 of the Capital Companies Act. Revocation of previous authorisations.
Authorisation for the Company to acquire its own shares indirectly. Revocation of previous authorisations.
Delegation of powers.
Questions and comments.
Drafting, reading and, where applicable, approval of the minutes.
Shareholders holding at least 10,000 shares who are recorded as holders in the relevant book-entry register five (5) days prior to the meeting may attend the general meeting; they may prove this by means of the appropriate attendance card, a certificate issued by the custodian institution affiliated with the Society for the Management of Registration, Compensación y Liquidación de Valores, S.A. (IBERCLEAR) or by any other means permitted by law.
Any shareholder entitled to attend may be represented at the meeting by another person, even if that person is not a shareholder. The proxy must be granted in writing and specifically for each general meeting.
The Attendance and Proxy Form for the convened general meeting can be found on the
Company's corporate website (https://www.kompuestos.com).
Right to information:It is hereby noted that shareholders have the right to examine, at the registered office, immediately and free of charge, the full text of the proposed resolutions included on the agenda, as well as any other documentation that must be made available to shareholders in connection with the holding of this general meeting. Shareholders may request that such documents be handed over or sent to them free of charge.
It is hereby noted that the documents relating to the general meeting of shareholders may be
consulted on the Company's corporate website (https://www.kompuestos.com).
In particular, it is hereby noted that, from the date of publication of this notice of meeting, shareholders are entitled to examine and obtain at the Company's registered office, and to request that they be sent, immediately and free of charge, copies of the following documents:
the Company's annual accounts and management reports, together with the
corresponding audit reports;
the proposed appropriation of profits, all relating to the financial year 2025;
the mandatory reports of the Board of Directors; and
the proposed resolutions.
All the documents mentioned above may also be consulted on the Company's corporate website
(https://www.kompuestos.com).
Up to the seventh day prior to the date scheduled for the meeting, shareholders may request from the directors any information or clarifications they deem necessary regarding the items on the agenda, or submit in writing any questions they consider relevant. Requests for information may be made by delivering the request to the registered office, or by sending it to the Company by post addressed to the registered office.
Supplement to the notice of meeting:In accordance with the provisions of Article 172 of the Companies Act, shareholders representing at least 5% of the share capital may request the publication of a supplement to this notice of meeting including one or more items on the agenda. This right must be exercised by means of a certified notification (which must include the relevant documentation proving the status of shareholder holding the aforementioned percentage) which must be received at the registered office within five days of the publication of this notice of meeting.
Palau Solità i Plegamans (Barcelona), 14 May 2026. Corporation Chimique International S.P.R.L.
On behalf of Mr Ignacio Duch Tuesta Chairman of the Board of Directors